Skip Navigation



BJA Advance Access published online on November 23, 2007
British Journal of Anaesthesia, doi:10.1093/bja/aem279
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
100/1/125    most recent
aem279v1
Right arrow E-Letters: Submit a response to the article
Right arrow E-letters: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rai, M. R.
Right arrow Articles by Warner, O. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rai, M. R.
Right arrow Articles by Warner, O. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Board of Management and Trustees of the British Journal of Anaesthesia 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial

M. R. Rai1, T. M. Parry1, A. Dombrovskis2 and O. J. Warner1,*

1 Nuffield Department of Anaesthetics, Oxford Radcliffe NHS Trust, Headley Way, Headington, Oxford OX3 9DU, UK
2 Epsom General Hospital, Dorking Road, Epsom, Surrey KT18 7EG, UK

* Corresponding author. E-mail: orlandowarner{at}regatta.plus.com

Background: Awake fibreoptic intubation (AFOI) is a technique used in patients with difficult airways. This study compares the suitability of remifentanil target-controlled infusion (TCI) to propofol TCI for conscious sedation during AFOI in patients with bona fide difficult airways.

Methods: We recruited 24, ASA I–III patients, who were undergoing sedation for elective AFOI. Patients were randomized to one of the two groups, Group P (n=10) received propofol TCI and Group R (n=14) received remifentanil TCI. Primary outcome measures were conditions achieved at endoscopy, intubation, and post-intubation, which were graded using scoring systems. Other parameters measured were the endoscopy time, intubation time, and number of attempts at intubation. A postoperative interview was conducted to determine recall of events and level of patient satisfaction.

Results: Endoscopy scores (0–5) and intubation scores (0–5) were significantly different [Group P 3 (1–4) vs Group R 1 (0–3) P<0.0001, Group P 3 (2–4) vs Group R 1 (0–3) P<0.0001, respectively]; with much better conditions in Group R, endoscopy times and intubation times were also significantly different, being shorter in Group R (P<0.007 and P<0.023, respectively). Patient tolerance of the procedure, judged by the discomfort scores (P<0.004) and the post-intubation scores (P<0.08), was significantly better in Group R. The level of recall for events was higher in Group R. However, there were no significant differences in the patient satisfaction scores.

Conclusions: Remifentanil TCI appears to provide better conditions for AFOI when compared with propofol TCI. The disadvantage of remifentanil in this setting may be a higher incidence of recall.

Keywords: anaesthetic techniques, fibreoptic; anaesthetics i.v., propofol; analgesics opioid, remifentanil; sedation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
J. Raeder
Opioid or Propofol: What Kind of Drug for What Kind of Sedation? Manual Dosing or Target-Controlled Infusion?
Anesth. Analg., March 1, 2009; 108(3): 704 - 706.
[Full Text] [PDF]

E-letters:

Read all E-letters

Remifentanil vs propofol for awake fibreoptic Intubation
Sally J Hargreaves, et al.
British Journal of Anaesthesia, 22 Jan 2008 [Full text]
Increasing acceptance of Remifentanil for Sedation in Awake Fibreoptic Intubation
Glyn D Harrison, et al.
British Journal of Anaesthesia, 12 Feb 2008 [Full text]
Remifentanil vs Propofol for awake fibreoptic intubation
Mario Shekar
British Journal of Anaesthesia, 29 Feb 2008 [Full text]

Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.